Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 9, 1998

View Archived Issues

Transgène, AFM Extension: FFr84M For Gene Therapies

Neurotech Raises FFr 82M In Second Financing Round

ExonHit, Cerep Enter FFr16M Neurodegenerative Disease Deal

Cortecs' Stock Drops By Half With News On Lead Programs

Introgene Signs Two More Deals For Vector System

Mammal Nerve-Cell Protein May Hold Memory Clues

Powderject's DNA Vaccine Gets Hepatitis B Response

Pharming, Alabama Firm Enter Deal For Lactoferrin

Researchers Find 'Flash' Function In Muscle Genes

Israel's Biotech Industry Organizes To Boost Growth

Biota, Virax Stocks Jump On Good Company News

Correction (Article updated in database)

Other News to Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...